Entrada Therapeutics, Inc. (TRDA)
14.04
+0.15
(+1.08%)
USD |
NASDAQ |
Apr 14, 16:00
14.04
0.00 (0.00%)
After-Hours: 20:00
Entrada Therapeutics Cash from Investing (TTM) : 116.81M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Tyra Biosciences, Inc. | 72.46M |
| Biogen, Inc. | -1.371B |
| EyePoint Plc | 68.58M |
| Vertex Pharmaceuticals, Inc. | -945.40M |
| Arcutis Biotherapeutics, Inc. | -30.25M |